CA2136331A1
New pharmaceutical uses of krill enzymes
Abstract
2136331 9324142 PCTABS00028 Non-immunogenic enzyme compositions which have been isolated from antarctic krill and exhibit both endo- and exo-peptidase activity, are useful for the manufacture of medicaments and pharmaceutical compositions for the treatment of a great variety of diseases in humans and animals such as infections, inflammations, cancers, HIV/AIDS, pain, polyps, warts, hemorrhoids, plaque, wrinkles, thin hair, allergic itch, anti-adhesion, eye diseases such as cataract, glaucom, etc.
Term
Term ended
Projected expiry passed 21 May 2013, 13.3 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
69 members in 26 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 9201628 | Sweden | A | |
| 9201628 | Sweden | A | |
| 9300455 | Sweden | W | |
| 9300455 | Sweden | W | |
| 92016286 | – | – | – |
| PCTSE93000455 | – | – | – |
| SE19920001628 | – | – | – |
| WO1993SE00455 | – | – | – |
Members69
| Document | Office | Kind | |
|---|---|---|---|
| SE9201628D0 | Sweden | D0 | |
| CA2136331A1This record | Canada | A1 | |
| CA2306952A1 | Canada | A1 | |
| WO9324142A1 | World Intellectual Property Organization (WIPO) | A1 | |
| ZA933598B | South Africa | B | |
| AU4100093A | Australia | A | |
| CN1089505A | China | A | |
| NO944448D0 | Norway | D0 | |
| NO944448L | Norway | L | |
| HU9403343D0 | Hungary | D0 | |
| EP0642351A1 | European Patent Office (EPO) | A1 | |
| CZ286794A3 | Czechia | A3 | |
| HUT69989A | Hungary | A | |
| JPH08501068A | Japan | A | |
| IL117060D0 | Israel | D0 | |
| CA2212533A1 | Canada | A1 | |
| WO9624371A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4917096A | Australia | A | |
| ZA961030B | South Africa | B | |
| SK140594A3 | Slovakia | A3 | |
| RU94046254A | Russian Federation | A | |
| AU675942B2 | Australia | B2 | |
| NO973627D0 | Norway | D0 | |
| IS4539A | Iceland | A | |
| NO973627L | Norway | L | |
| EP0810875A1 | European Patent Office (EPO) | A1 | |
| BR9607506A | Brazil | A | |
| EP0824910A2 | European Patent Office (EPO) | A2 | |
| EA199700167A1 | Eurasian Patent Organization (EAPO) | A1 | |
| EP0824910A3 | European Patent Office (EPO) | A3 | |
| CZ254197A3 | Czechia | A3 | |
| EP0838213A1 | European Patent Office (EPO) | A1 | |
| CN1181018A | China | A | |
| PL324085A1 | Poland | A1 | |
| MX9706095A | Mexico | A | |
| KR19980702081A | Republic of Korea | A | |
| JPH11502102A | Japan | A | |
| HU9900338A2 | Hungary | A2 | |
| HUP9900338A2 | Hungary | A2 | |
| US5945102A | United States of America | A | |
| EP0810875A4 | European Patent Office (EPO) | A4 | |
| US5958406A | United States of America | A | |
| US6030612A | United States of America | A | |
| AU718220B2 | Australia | B2 | |
| JP2000351734A | Japan | A | |
| NZ302984A | New Zealand | A | |
| KR100290266B1 | Republic of Korea | B1 | |
| US6232088B1 | United States of America | B1 | |
| NZ503162A | New Zealand | A | |
| EP0642351B1 | European Patent Office (EPO) | B1 | |
| AT214610T | Austria | T | |
| ATE214610T1 | Austria | T1 | |
| DE69331739D1 | Germany | D1 | |
| DK0642351T3 | Denmark | T3 | |
| CN1090505C | China | C | |
| CN1090507C | China | C | |
| ES2173887T3 | Spain | T3 | |
| DE69331739T2 | Germany | T2 | |
| US2005025722A1 | United States of America | A1 | |
| CA2136331C | Canada | C | |
| EP0838213B1 | European Patent Office (EPO) | B1 | |
| AT311853T | Austria | T | |
| ATE311853T1 | Austria | T1 | |
| DE69333931D1 | Germany | D1 | |
| ES2255097T3 | Spain | T3 | |
| US2006134641A1 | United States of America | A1 | |
| DE69333931T2 | Germany | T2 | |
| JP4012665B2 | Japan | B2 | |
| US7947270B2 | United States of America | B2 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| LapsedLapsedMKLA | MKLA | |
| Examination requestEEER | EEER |
Numbers
- Publication, DOCDB
- 2136331
- Publication, EPODOC
- CA2136331
- Application
- 2136331
- Application, DOCDB
- 2136331
- Application, EPODOC
- CA19932136331
Titles2
- English
- NEW PHARMACEUTICAL USES OF KRILL ENZYMES
- French
- NOUVEAUX USAGES PHARMACEUTIQUES D'ENZYMES DE KRILL
Classification
- CPC, 31
- A61K8/66
- A61K8/987
- A61K38/00
- A61Q11/00
- C12N9/48
- C12N9/6402
- A61P1/00
- A61P1/02
- A61P1/04
- A61P11/00
- A61P13/02
- A61P15/00
- A61P17/00
- A61P25/00
- A61P25/04
- A61P27/00
- A61P27/02
- A61P27/06
- A61P27/12
- A61P27/14
- A61P29/00
- A61P31/00
- A61P31/04
- A61P31/12
- A61P31/18
- A61P33/06
- A61P35/00
- A61P37/00
- A61P37/08
- A61P43/00
- Y02A50/30
- IPC, 39
- A61K8 00
- A61K
- A61K6 00
- A61K8 66
- A61K8 98
- A61K35 56
- A61K38 00
- A61K38 46
- A61K38 48
- A61K38 54
- A61P1 00
- A61P1 02
- A61P1 04
- A61P11 00
- A61P13 02
- A61P15 00
- A61P17 00
- A61P25 00
- A61P25 04
- A61P27 00
- A61P27 02
- A61P27 06
- A61P27 12
- A61P27 14
- A61P29 00
- A61P31 04
- A61P31 12
- A61P31 18
- A61P33 06
- A61P35 00
- A61P37 00
- A61P37 08
- A61P43 00
- A61Q5 00
- A61Q7 00
- A61Q11 00
- C12N9 48
- C12N9 50
- C12N9 64